Salani, Jawlisa B.

HRN: 25-19-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2024
CEFUROXIME 750MG (VIAL)
06/15/2024
06/22/2024
IV DRIP
240mg
Q8H
PCAP C
Waiting Final Action 
06/15/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/15/2024
06/22/2024
IV
110mg
Q24H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: